Fresenius Medical Care Corp (FMS) 42.65 $FMS
Uptrend Call Working As Fresenius Medical Care Stock Rises 19.3% (FMS)
Comtex SmarTrend(R) - Wed Apr 22, 9:29AM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 6 months, Fresenius Medical Care has returned 19.34% as of today's recent price of $42.71.
FMS: 42.65 (-0.50)
Medicare Pay Plan Elevates Outpatient And Home Health
at Investor's Business Daily - Fri Apr 17, 3:41PM CDT
Medicare physicians aren't the only ones relieved by Congress bringing down the curtain on 17 years of recurring debates, with a $214 billion doc fix that avoided a 21% cut in reimbursement and offered some payment relief to the home health care...
KND: 24.18 (+0.26), AMSG: 64.72 (-0.54), AFAM: 44.60 (-0.22), DVA: 83.22 (+0.10), LHCG: 34.07 (-0.41), THC: 50.58 (-0.27), BKD: 37.00 (+0.13), FMS: 42.65 (-0.50), AMED: 26.07 (+0.03), HLS: 46.35 (+0.48), MD: 73.00 (+0.12)
Fresenius Medical Care Releases 2015 Annual Medical Quality Report
Business Wire - Thu Apr 16, 7:30AM CDT
Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care (NYSE: FMS) and North America's largest provider of kidney care, hospitalist services and renal products, announced today the release of its 2015 Annual Medical Quality Report (AMQR).
FMS: 42.65 (-0.50)
Uptrend Call Working As Fresenius Medical Care Stock Rises 21.0% (FMS)
Comtex SmarTrend(R) - Tue Apr 14, 5:11PM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 6 months, Fresenius Medical Care has returned 20.96% as of today's recent price of $43.29.
FMS: 42.65 (-0.50)
19.3% Return Seen to Date on SmarTrend Fresenius Medical Care Call (FMS)
Comtex SmarTrend(R) - Tue Apr 07, 11:35AM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 6 months, Fresenius Medical Care has returned 19.28% as of today's recent price of $42.69.
FMS: 42.65 (-0.50)
Specialists On Call Appoints Hammad Shah as Chief Executive Officer
Business Wire - Wed Mar 25, 3:35PM CDT
Specialists On Call, Inc. ("SOC"
, the leading provider of specialty telemedicine services to hospitals, today announced the appointment of Hammad Shah as Chief Executive Officer ("CEO". Mr. Shah's appointment will strengthen SOC's capabilities to meet the growing demand for its services and its continued dedication to improved patient care.
ESRX: 86.12 (+0.02), CVS: 101.23 (-0.18), FMS: 42.65 (-0.50)
Renal Research Institute Fellow Receives International Society of Nephrology Award
Business Wire - Wed Mar 25, 6:00AM CDT
Renal Research Institute (RRI), a division of Fresenius Medical Care North America, announced today that judges at the International Society of Nephrology's (ISN) World Congress of Nephrology (WCN) in Cape Town, South Africa, have awarded RRI Research Fellow Dr. Viviane Calice-Silva the ISN's Fellowship Poster 3rd prize.
FMS: 42.65 (-0.50)
Fresenius Medical: 52-Week High on Solid Q4, Bright View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 2:30PM CDT
Shares of Fresenius Medical Care AG & Co. KGAA (FMS) reached a new 52-week high of $42.85 on Mar 16, eventually closing a few cents lower at $42.10
ABAX: 63.25 (-0.09), FMS: 42.65 (-0.50), LMNX: 16.34 (-0.01), AFFX: 12.57 (-0.13)
Fresenius Medical Care Has Returned 17.6% Since SmarTrend Recommendation (FMS)
Comtex SmarTrend(R) - Mon Mar 16, 5:24PM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 5 months, Fresenius Medical Care has returned 17.63% as of today's recent price of $42.10.
FMS: 42.65 (-0.50)
Fresenius Medical Care Supports World Kidney Day by Raising Awareness of Kidney Disease and the Need for Regular Screenings
Business Wire - Thu Mar 12, 1:44PM CDT
In support of World Kidney Day today, and throughout National Kidney Month in March, Fresenius Medical Care is raising awareness of the importance of kidney health by encouraging the public to learn about chronic kidney disease (CKD), as well as the risk factors that can lead to CKD, and consider getting screened for the disease.
FMS: 42.65 (-0.50)
Heritage Provider Network and Fresenius Medical Care Announce Physician Network Development and Care Coordination Collaboration
Business Wire - Thu Mar 12, 6:00AM CDT
Heritage Development Organization, an affiliate of Heritage Provider Network (HPN), a national leader in coordinated care and integrated delivery network development and Fresenius Medical Care (NYSE: FMS), a diversified health care company and North America's largest provider of kidney care and hospitalist services, announced an agreement today to develop physician networks and care coordination and population health management services in select markets throughout the country. The collaboration expands the two companies' successful partnership with shared savings models and furthers their commitment to improving value in health care, making coordinated, value-based care more accessible to all Americans.
FMS: 42.65 (-0.50)
Fresenius Medical Care Shares Up 14.8% Since SmarTrend's Buy Recommendation (FMS)
Comtex SmarTrend(R) - Mon Mar 02, 9:28AM CST
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 4 months, Fresenius Medical Care has returned 14.84% as of today's recent price of $41.10.
FMS: 42.65 (-0.50)
DaVita: Sometimes The Money Is Lying On The Street
Early Retiree - at Seeking Alpha - Fri Feb 27, 5:15AM CST
DVA: 83.22 (+0.10), FMS: 42.65 (-0.50)
Fresenius Medical Care (FMS) Tops Q4 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 9:08AM CST
Fresenius Medical Care (FMS) reported adjusted earnings of 56 cents per American Depositary Share (ADS) for the fourth quarter of 2014, topping the Zacks Consensus Estimate by 7 cents.
ABAX: 63.25 (-0.09), FMS: 42.65 (-0.50), LMNX: 16.34 (-0.01), AFFX: 12.57 (-0.13)
Fresenius Medical Care's (FMS) CEO Rice Powell on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 6:47PM CST
FMS: 42.65 (-0.50)
Fresenius Q4 earnings off 5%, CF Ops flat
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 11:13AM CST
FMS: 42.65 (-0.50)
3 Health Care Stocks Pushing Sector Growth
at The Street - Wed Feb 25, 11:06AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
UTHR: 187.98 (+0.12), FMS: 42.65 (-0.50), ICLR: 69.24 (+1.28)
Uptrend Call Working As Fresenius Medical Care Stock Rises 19.3% (FMS)
Comtex SmarTrend(R) - Wed Apr 22, 9:29AM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 6 months, Fresenius Medical Care has returned 19.34% as of today's recent price of $42.71.
FMS: 42.65 (-0.50)
Medicare Pay Plan Elevates Outpatient And Home Health
at Investor's Business Daily - Fri Apr 17, 3:41PM CDT
Medicare physicians aren't the only ones relieved by Congress bringing down the curtain on 17 years of recurring debates, with a $214 billion doc fix that avoided a 21% cut in reimbursement and offered some payment relief to the home health care...
KND: 24.18 (+0.26), AMSG: 64.72 (-0.54), AFAM: 44.60 (-0.22), DVA: 83.22 (+0.10), LHCG: 34.07 (-0.41), THC: 50.58 (-0.27), BKD: 37.00 (+0.13), FMS: 42.65 (-0.50), AMED: 26.07 (+0.03), HLS: 46.35 (+0.48), MD: 73.00 (+0.12)
Fresenius Medical Care Releases 2015 Annual Medical Quality Report
Business Wire - Thu Apr 16, 7:30AM CDT
Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care (NYSE: FMS) and North America's largest provider of kidney care, hospitalist services and renal products, announced today the release of its 2015 Annual Medical Quality Report (AMQR).
FMS: 42.65 (-0.50)
Uptrend Call Working As Fresenius Medical Care Stock Rises 21.0% (FMS)
Comtex SmarTrend(R) - Tue Apr 14, 5:11PM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 6 months, Fresenius Medical Care has returned 20.96% as of today's recent price of $43.29.
FMS: 42.65 (-0.50)
19.3% Return Seen to Date on SmarTrend Fresenius Medical Care Call (FMS)
Comtex SmarTrend(R) - Tue Apr 07, 11:35AM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 6 months, Fresenius Medical Care has returned 19.28% as of today's recent price of $42.69.
FMS: 42.65 (-0.50)
Specialists On Call Appoints Hammad Shah as Chief Executive Officer
Business Wire - Wed Mar 25, 3:35PM CDT
Specialists On Call, Inc. ("SOC"
, the leading provider of specialty telemedicine services to hospitals, today announced the appointment of Hammad Shah as Chief Executive Officer ("CEO". Mr. Shah's appointment will strengthen SOC's capabilities to meet the growing demand for its services and its continued dedication to improved patient care. ESRX: 86.12 (+0.02), CVS: 101.23 (-0.18), FMS: 42.65 (-0.50)
Renal Research Institute Fellow Receives International Society of Nephrology Award
Business Wire - Wed Mar 25, 6:00AM CDT
Renal Research Institute (RRI), a division of Fresenius Medical Care North America, announced today that judges at the International Society of Nephrology's (ISN) World Congress of Nephrology (WCN) in Cape Town, South Africa, have awarded RRI Research Fellow Dr. Viviane Calice-Silva the ISN's Fellowship Poster 3rd prize.
FMS: 42.65 (-0.50)
Fresenius Medical: 52-Week High on Solid Q4, Bright View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 2:30PM CDT
Shares of Fresenius Medical Care AG & Co. KGAA (FMS) reached a new 52-week high of $42.85 on Mar 16, eventually closing a few cents lower at $42.10
ABAX: 63.25 (-0.09), FMS: 42.65 (-0.50), LMNX: 16.34 (-0.01), AFFX: 12.57 (-0.13)
Fresenius Medical Care Has Returned 17.6% Since SmarTrend Recommendation (FMS)
Comtex SmarTrend(R) - Mon Mar 16, 5:24PM CDT
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 5 months, Fresenius Medical Care has returned 17.63% as of today's recent price of $42.10.
FMS: 42.65 (-0.50)
Fresenius Medical Care Supports World Kidney Day by Raising Awareness of Kidney Disease and the Need for Regular Screenings
Business Wire - Thu Mar 12, 1:44PM CDT
In support of World Kidney Day today, and throughout National Kidney Month in March, Fresenius Medical Care is raising awareness of the importance of kidney health by encouraging the public to learn about chronic kidney disease (CKD), as well as the risk factors that can lead to CKD, and consider getting screened for the disease.
FMS: 42.65 (-0.50)
Heritage Provider Network and Fresenius Medical Care Announce Physician Network Development and Care Coordination Collaboration
Business Wire - Thu Mar 12, 6:00AM CDT
Heritage Development Organization, an affiliate of Heritage Provider Network (HPN), a national leader in coordinated care and integrated delivery network development and Fresenius Medical Care (NYSE: FMS), a diversified health care company and North America's largest provider of kidney care and hospitalist services, announced an agreement today to develop physician networks and care coordination and population health management services in select markets throughout the country. The collaboration expands the two companies' successful partnership with shared savings models and furthers their commitment to improving value in health care, making coordinated, value-based care more accessible to all Americans.
FMS: 42.65 (-0.50)
Fresenius Medical Care Shares Up 14.8% Since SmarTrend's Buy Recommendation (FMS)
Comtex SmarTrend(R) - Mon Mar 02, 9:28AM CST
SmarTrend identified an Uptrend for Fresenius Medical Care (NYSE:FMS) on October 24th, 2014 at $35.79. In approximately 4 months, Fresenius Medical Care has returned 14.84% as of today's recent price of $41.10.
FMS: 42.65 (-0.50)
DaVita: Sometimes The Money Is Lying On The Street
Early Retiree - at Seeking Alpha - Fri Feb 27, 5:15AM CST
DVA: 83.22 (+0.10), FMS: 42.65 (-0.50)
Fresenius Medical Care (FMS) Tops Q4 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 9:08AM CST
Fresenius Medical Care (FMS) reported adjusted earnings of 56 cents per American Depositary Share (ADS) for the fourth quarter of 2014, topping the Zacks Consensus Estimate by 7 cents.
ABAX: 63.25 (-0.09), FMS: 42.65 (-0.50), LMNX: 16.34 (-0.01), AFFX: 12.57 (-0.13)
Fresenius Medical Care's (FMS) CEO Rice Powell on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 6:47PM CST
FMS: 42.65 (-0.50)
Fresenius Q4 earnings off 5%, CF Ops flat
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 11:13AM CST
FMS: 42.65 (-0.50)
3 Health Care Stocks Pushing Sector Growth
at The Street - Wed Feb 25, 11:06AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
UTHR: 187.98 (+0.12), FMS: 42.65 (-0.50), ICLR: 69.24 (+1.28)
